BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

Cell Metabolism is an esteemed journal published by CELL PRESS, dedicated to advancing the understanding of metabolic processes within cell biology, molecular biology, and physiology. With an impactful 2023 ranking placing it at Q1 in multiple categories and earning a distinguished position in the top percentiles of its respective fields, this journal serves as an essential resource for researchers, professionals, and students who are investigating the dynamic roles of metabolism in health and disease. Its rigorous peer-review process ensures high-quality publications that reflect the latest advancements in metabolic research. Since its inception in 2005, Cell Metabolism has become a pivotal platform for disseminating critical findings that not only expand scientific knowledge but also foster innovative approaches to tackle metabolic disorders. By prioritizing accessibility and scholarly excellence without the Open Access model, it remains a premier source for cutting-edge research insights.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

International Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

Correspondances en Metabolismes Hormones Diabetes et Nutrition is a vital resource for researchers and practitioners in the fields of endocrinology, diabetes, and nutrition, published by EDIMARK SANTE in France. Established since 2009, this journal diligently focuses on the evolving relationship between metabolic processes and hormonal regulation, catering to the interdisciplinary nexus of food science and medicine. Although currently classified in the Q4 quartile for 2023 in its respective categories, the journal remains significant for its contributions to understanding metabolic disorders and nutritional impacts on health. With the growing global obesity epidemic and increasing diabetes prevalence, the journal aims to disseminate cutting-edge research, case studies, and reviews that will foster discussion and prompt innovation in treatment and dietary strategies. While it follows a traditional publishing model, its aim is to enhance accessibility to critical findings for a wide audience, from corporate researchers to clinical practitioners and students seeking in-depth knowledge in this crucial area.

Archives of Physiology and Biochemistry, published by Taylor & Francis Ltd, is a renowned journal that has been pivotal in advancing knowledge and research in the fields of physiology and biochemistry since its inception. With an impact factor reflective of its significant contributions, this journal is categorized in Q2 in Medicine (miscellaneous) and Q3 in Physiology, underscoring its relevance and scholarly impact within the scientific community. The journal publishes original research articles, review papers, and innovative methodologies that explore the intricate relationships between physiological functions and biochemical processes. With its commitment to fostering scientific discourse, the Archives of Physiology and Biochemistry serves as an essential resource for researchers, professionals, and students alike, providing insights and evidence that drive forward the frontiers of medical and physiological science. The journal is accessible in both print and online formats, ensuring that critical research reaches a wide audience.

Frontiers in Physiology, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of physiological research since its inception in 2010. As a reputable publication based in Switzerland, it aims to foster the dissemination of groundbreaking findings across various domains of physiology, engaging a global audience of scholars and practitioners. With a commendable Q2 ranking in the fields of both general physiology and medical physiology for 2023, this journal stands out in its field, achieving a significant Scopus rank of #32/113 in medical physiology and #58/193 in biochemistry, genetics, and molecular biology. Frontiers in Physiology not only commits to maintaining high scholarly standards but also ensures that all its articles are freely accessible, thereby promoting collaborative knowledge exchange. With a clear focus on advancing our understanding of physiological processes, the journal plays a crucial role in the development of innovative approaches to health and disease, making it an essential resource for researchers, professionals, and students alike.

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.